Ophthalmic Devices - Australia & Oceania

  • Australia & Oceania
  • The projected revenue in the Ophthalmic Devices market market in Australia & Oceania is estimated to reach US$0.62bn in 2024.
  • It is expected that the revenue will experience an annual growth rate (CAGR 2024-2028) of 6.25%, leading to a market volume of US$0.79bn by 2028.
  • When compared globally, the United States is anticipated to generate the highest revenue of US$14,150.00m in 2024.
  • Australia & Oceania has witnessed a growing demand for advanced ophthalmic devices due to the region's aging population and increasing prevalence of eye diseases.

Key regions: Netherlands, Japan, United States, Spain, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Ophthalmic Devices market in Australia & Oceania is experiencing steady growth due to customer preferences for advanced technology and the increasing prevalence of eye-related disorders. Customer preferences in the Ophthalmic Devices market in Australia & Oceania are shifting towards advanced technology and innovative solutions. Customers are increasingly seeking devices that offer improved accuracy, precision, and ease of use. This preference is driven by the desire for better diagnostic and treatment options, as well as the increasing adoption of minimally invasive procedures. Additionally, customers are also demanding devices that offer better connectivity and integration with electronic health records, allowing for seamless data management and analysis. Trends in the market include the growing prevalence of eye-related disorders, such as cataracts, glaucoma, and age-related macular degeneration. These conditions are becoming more common due to factors such as an aging population, changing lifestyles, and increased exposure to digital screens. As a result, there is a growing demand for ophthalmic devices that can effectively diagnose and treat these conditions. In particular, there is a rising demand for devices that offer non-invasive and minimally invasive treatment options, as they provide patients with faster recovery times and fewer complications. Local special circumstances in Australia & Oceania include the presence of a well-established healthcare system and a high level of healthcare expenditure. This allows for a greater adoption of advanced ophthalmic devices and technologies. Additionally, the region has a strong focus on research and development, leading to the development of innovative solutions in the ophthalmic field. The presence of a skilled workforce and a supportive regulatory environment further contribute to the growth of the market. Underlying macroeconomic factors driving the development of the Ophthalmic Devices market in Australia & Oceania include a growing population, increasing disposable income, and improving healthcare infrastructure. The region's aging population is particularly significant, as older individuals are more likely to develop eye-related disorders and require ophthalmic devices. Additionally, rising disposable income levels allow individuals to afford advanced ophthalmic devices and treatments. The improving healthcare infrastructure, including the availability of specialized ophthalmic clinics and hospitals, further supports the growth of the market. Overall, the Ophthalmic Devices market in Australia & Oceania is developing due to customer preferences for advanced technology, the increasing prevalence of eye-related disorders, local special circumstances, and underlying macroeconomic factors. As these factors continue to drive market growth, it is expected that the Ophthalmic Devices market in Australia & Oceania will continue to expand in the coming years.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)